Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Shares Outstanding (2021 - 2025)

Coeptis Therapeutics Holdings has reported Shares Outstanding over the past 5 years, most recently at $5.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $5.7 million for Q4 2025, up 171.57% from a year ago — trailing twelve months through Dec 2025 was $5.7 million (up 171.57% YoY), and the annual figure for FY2025 was $5.7 million, up 171.57%.
  • Shares Outstanding for Q4 2025 was $5.7 million at Coeptis Therapeutics Holdings, up from $4.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for COEPW hit a ceiling of $24.4 million in Q2 2023 and a floor of $3800.0 in Q1 2025.
  • Median Shares Outstanding over the past 5 years was $2.0 million (2023), compared with a mean of $6.1 million.
  • Peak annual rise in Shares Outstanding hit 96800.3% in 2025, while the deepest fall reached 99.79% in 2025.
  • Coeptis Therapeutics Holdings' Shares Outstanding stood at $12.5 million in 2021, then tumbled by 92.17% to $978342.0 in 2022, then soared by 80.57% to $1.8 million in 2023, then increased by 19.79% to $2.1 million in 2024, then skyrocketed by 171.57% to $5.7 million in 2025.
  • The last three reported values for Shares Outstanding were $5.7 million (Q4 2025), $4.2 million (Q2 2025), and $3800.0 (Q1 2025) per Business Quant data.